telmisartan has been researched along with Amentia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TH; Huang, CC; Huang, WK; Lee, TH; Lee, TW; Li, YR; Liu, CH; Sung, PS; Wei, YC | 1 |
| Anderson, C; Bosch, J; Gao, P; Joseph, PG; Khatib, R; O'Donnell, MJ; Probstfield, JL; Teo, KK; Yusuf, S | 1 |
| Anderson, C; Cukierman-Yaffe, T; Gao, P; Gerstein, HC; Teo, K; Yusuf, S | 1 |
| Jaggi, AS; Sharma, B; Singh, B; Singh, N | 1 |
2 trial(s) available for telmisartan and Amentia
| Article | Year |
|---|---|
The mini-mental state examination, clinical factors, and motor vehicle crash risk.
Topics: Accidents, Traffic; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Automobile Driving; Benzimidazoles; Benzoates; Cardiovascular Diseases; Dementia; Diabetes Complications; Female; Humans; Male; Neuropsychological Tests; Predictive Value of Tests; Prospective Studies; Ramipril; Risk; Telmisartan | 2014 |
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies.
Topics: Aged; Aged, 80 and over; Aging; Benzimidazoles; Benzoates; Cardiovascular Diseases; Chronic Disease; Cognition Disorders; Dementia; Disabled Persons; Female; Glucose Metabolism Disorders; Humans; Male; Middle Aged; Ramipril; Risk Factors; Telmisartan | 2015 |
2 other study(ies) available for telmisartan and Amentia
| Article | Year |
|---|---|
Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Asian People; Cohort Studies; Dementia; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Taiwan; Telmisartan | 2021 |
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
Topics: Alzheimer Disease; Animals; Benzimidazoles; Benzoates; Congo Red; Dementia; Injections, Intraventricular; Lisinopril; Maze Learning; Mice; PPAR gamma; Reaction Time; Staining and Labeling; Streptozocin; Telmisartan | 2013 |